↓ Skip to main content

Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression

Overview of attention for article published in Molecular Cancer, August 2005
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

patent
3 patents
wikipedia
1 Wikipedia page

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression
Published in
Molecular Cancer, August 2005
DOI 10.1186/1476-4598-4-28
Pubmed ID
Authors

Thomas E Sussan, Mathew T Pletcher, Yoshinori Murakami, Roger H Reeves

Abstract

Introduction of cDNA or genomic clones of the tumor suppressor in lung cancer 1 (TSLC1) gene into the non-small cell lung cancer line, A549, reverses tumorigenic growth properties of these cells. These results and the observation that TSLC1 is down-regulated in a number of tumors suggest that TSLC1 functions as a critical switch mediating repression of tumorigenesis.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 20%
Professor > Associate Professor 4 20%
Researcher 3 15%
Professor 2 10%
Student > Master 2 10%
Other 4 20%
Unknown 1 5%
Readers by discipline Count As %
Medicine and Dentistry 5 25%
Agricultural and Biological Sciences 5 25%
Neuroscience 3 15%
Biochemistry, Genetics and Molecular Biology 2 10%
Arts and Humanities 1 5%
Other 1 5%
Unknown 3 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 November 2017.
All research outputs
#2,459,753
of 22,789,076 outputs
Outputs from Molecular Cancer
#126
of 1,719 outputs
Outputs of similar age
#4,168
of 57,246 outputs
Outputs of similar age from Molecular Cancer
#1
of 5 outputs
Altmetric has tracked 22,789,076 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,719 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 57,246 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them